ES2041243T3 - Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus. - Google Patents

Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus.

Info

Publication number
ES2041243T3
ES2041243T3 ES198686402716T ES86402716T ES2041243T3 ES 2041243 T3 ES2041243 T3 ES 2041243T3 ES 198686402716 T ES198686402716 T ES 198686402716T ES 86402716 T ES86402716 T ES 86402716T ES 2041243 T3 ES2041243 T3 ES 2041243T3
Authority
ES
Spain
Prior art keywords
destructive
living
virus
composition
principle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686402716T
Other languages
English (en)
Inventor
Pierre Bourbon
Pierre Billot
Pierre Lagny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atlantic Pharmaceutical Products Ltd
Original Assignee
Atlantic Pharmaceutical Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atlantic Pharmaceutical Products Ltd filed Critical Atlantic Pharmaceutical Products Ltd
Application granted granted Critical
Publication of ES2041243T3 publication Critical patent/ES2041243T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/10—Fluorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Abstract

LA INVENCION TRATA DE UNA SUSTANCIA O COMPOSICION FARMACEUTICA O COSMETICA INHIBIDORA O DESTRUCTIVA DE UN SER VIVO UNICELULAR, Y/O UN VIRUS POR LO MENOS, UN MEDICAMENTO O UN PRODUCTO QUE CONTIENE TAL COMPOSICION, UN PROCEDIMIENTO DE PREPARACION DE ESTA COMPOSICION, UN COMPUESTO QUIMICO QUE ENTRA EN ESTA COMPOSICION Y UN PROCEDIMIENTO DE INHIBICION O DESTRUCCION DE UN SER VIVO UNICELULAR Y/O UN VIRUS POR LO MENOS. LA SUSTANCIA INHIBIDORA O DESTRUCTIVA SEGUN LA INVENCION SE CARACTERIZA PORQUE TIENE POR LO MENOS UN PRINCIPIO ACTIVO DE BASE INHIBIDOR O DESTRUCTIVO DE DICHO SER VIVO UNICELULAR Y UN PRINCIPIO INHIBIDOR O DESTRUCTIVO DE POR LO MENOS UN ENZIMA ASOCIADO A DICHO SER VIVO, CONSTITUYENDO UN ACTIVADOR, ESPECIALMENTE ACTIVADO POR SINERGIA, DEL PRINCIPIO ACTIVO DE BASE.
ES198686402716T 1986-05-22 1986-12-08 Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus. Expired - Lifetime ES2041243T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8607310A FR2598916B1 (fr) 1986-05-22 1986-05-22 Compose chimique fluore utilise dans une methode de contraception locale et composition contraceptive locale fluoree, notamment spermicide

Publications (1)

Publication Number Publication Date
ES2041243T3 true ES2041243T3 (es) 1993-11-16

Family

ID=9335493

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686402716T Expired - Lifetime ES2041243T3 (es) 1986-05-22 1986-12-08 Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus.

Country Status (8)

Country Link
US (1) US4917901A (es)
EP (1) EP0253037B1 (es)
KR (1) KR880701104A (es)
DD (1) DD279408A5 (es)
DE (1) DE3680108D1 (es)
ES (1) ES2041243T3 (es)
FR (1) FR2598916B1 (es)
ZA (1) ZA873548B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620698B1 (fr) * 1987-09-23 1990-08-10 Atlantic Pharma Prod Fluorure d'ammonium quaternaire et son application dans une substance inhibitrice ou destructrice d'etres vivants unicellulaires
US5380529A (en) * 1990-07-10 1995-01-10 Laboratoire Lucchini S.A. Pharmaceutical, vaginal applicable preparation and a process for its preparation
EP0491279A1 (de) * 1990-12-17 1992-06-24 Hewing GmbH Verfahren zur keimwachstumshemmenden Behandlung von Oberflächen von technischen Gegenständen und Hohlkörper zur Begrenzung flüssiger oder gasförmiger Medien
US5229423A (en) * 1992-03-06 1993-07-20 Albert Einstein College Of Medicine Of Yeshiva University Use of butylurea as a contraceptive agent
US5380762A (en) * 1993-02-02 1995-01-10 Buckman Laboratories International, Inc. Method for controlling macroinvertebrates
US5488075A (en) * 1994-09-20 1996-01-30 Guha; Sujoy K. Contraceptive for use by a male
US5778886A (en) * 1996-02-27 1998-07-14 Shihata; Alfred Vaginal compositions combining a spermicidal agent and a peroxygen compound
US6051603A (en) 1998-01-20 2000-04-18 Wayne Hughes Institute Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
US6432941B1 (en) 1998-01-20 2002-08-13 Parker Hughes Institute Vanadium compounds for treating cancer
US6245808B1 (en) 1998-11-05 2001-06-12 Parker Hughes Institute Oxy-vanadium (IV) complexes having spermicidal activity
US6579541B2 (en) 2000-03-28 2003-06-17 Marantech Holding, Llc Oxidative fluorinator compounds as antimicrobials
WO2015161860A1 (en) 2014-04-25 2015-10-29 Frank Flechsig Improved biocide compositions based on calcium fluoride as well as uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1297708A (fr) * 1958-05-29 1962-07-06 Gaba Ag Fluorures d'ammonium quaternaire et leurs procédés de fabrication
CH448388A (de) * 1963-12-30 1967-12-15 Ciba Geigy Neues Zahnpflegemittel
US3647700A (en) * 1967-08-14 1972-03-07 Commodity Improvements Inc K2zrf6
US3995029A (en) * 1975-01-02 1976-11-30 Geraldine Fay Weisz Methods for the treatment of acne
US3996350A (en) * 1975-01-02 1976-12-07 Geraldine Fay Weisz Methods and compositions for alleviating fungus infections of the skin
US4097590A (en) * 1975-07-24 1978-06-27 Geraldine Fay Weisz Methods and compositions for treatment of bacterial and fungus infections of the skin
SE444112B (sv) * 1978-06-15 1986-03-24 Dental Therapeutics Ab Rengoringsmedel for dentinytor
US4206233A (en) * 1978-11-03 1980-06-03 Petrolite Corporation Microbiocidal quaternaries of halogen derivatives of alkynoxymethyl amines
JPS57131714A (en) * 1980-12-24 1982-08-14 Warner Lambert Co Caries controlling method and composition
US4368186A (en) * 1981-05-07 1983-01-11 Syntex (U.S.A.) Inc. Methods and compositions for intravaginal contraception
US4359475A (en) * 1981-12-21 1982-11-16 Syntex (U.S.A.) Inc. Thioketal substituted N-alkyl imidazoles
US4473547A (en) * 1982-11-18 1984-09-25 Johnson & Johnson Products Inc. Anticaries compositions
US4490353A (en) * 1983-07-13 1984-12-25 Colgate-Palmolive Company Antiplaque dentifrice with improved fluoride stability
US4568540A (en) * 1984-04-18 1986-02-04 Johnson & Johnson Oral hygiene compositions
DE3543801A1 (de) * 1985-12-12 1987-06-25 Marquardt Bernd Pharmazeutisches produkt enthaltend ein gemisch aus benzoesaeure, phenol und ein alkalifluorid in waessriger oder waessrig-alkoholischer loesung und seine verwendung

Also Published As

Publication number Publication date
EP0253037B1 (fr) 1991-07-03
DE3680108D1 (de) 1991-08-08
EP0253037A1 (fr) 1988-01-20
FR2598916B1 (fr) 1988-09-09
FR2598916A1 (fr) 1987-11-27
US4917901A (en) 1990-04-17
KR880701104A (ko) 1988-07-25
ZA873548B (en) 1987-11-11
DD279408A5 (de) 1990-06-06

Similar Documents

Publication Publication Date Title
DK1296633T3 (da) Medicinalproduktpakning til udryddelsesbehandling
FI973419A0 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
ES2041243T3 (es) Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus.
AR015946A1 (es) Formulacion farmaceutica que comprende bifosfonatos, proceso para su preparacion, uso de la formulacion para la fabricacion de un medicamento, metodo parala inhibicion de la reabsorcion osea, y metodo para el tratamiento y prevencion de osteoporosis
DE69910230D1 (de) Paclitaxel enthaltende arzneimittel
GEP20043375B (en) APRIL-Receptor (BCMA) and Use Thereof
ES2058725T3 (es) Aplicacion transdermica de 2-amino-6-n-propilamino-4,5,6,7-tetrahidrobenzotiazol.
AR020055A1 (es) Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DE60138948D1 (de) Medizinische aerosolformulierung von antidiabetika
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
DE60234577D1 (de) Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält
AR003589A1 (es) Utilizacion de una cantidad eficaz de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento destinada paratratar la inflamacion, y un procedimiento de tratamiento cosmetico mediante una composicion cosmetica que contiene a dicho peptido.
HUP9904092A2 (hu) Gyógyszerkészítmény HIV és rák kezelésére valamint eljárás előállítására
ES2159403T3 (es) Poliuretanos termoplasticos que contienen principios activos.
DE69501419T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
MX9308005A (es) Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
UY25192A1 (es) Formulación medicamentosa con liberación controlada de sustancia activa
NO331082B1 (no) Formulering av kahalalid F, sett omfattende en slik formulering, samt rekonstituert losning derav og anvendelse av en fortynnet rekonstituert losning til fremstilling av et medikament for behandling av kreft
ES2080063T3 (es) Composiciones sinergicas que contienen imazalil.
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
BR9916893A (pt) Tratamento
MX9308025A (es) Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene.
ATE309817T1 (de) Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs
DE69909747D1 (de) Pharmazeutische zusammensetzung, enthaltend peg-asparaginase, für die behandlung von hiv infektionen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 253037

Country of ref document: ES